These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29803089)

  • 1. Performance of the Alere Determine™ HIV-1/2 Ag/Ab Combo Rapid Test with algorithm-defined acute HIV-1 infection specimens.
    Parker MM; Bennett SB; Sullivan TJ; Fordan S; Wesolowski LG; Wroblewski K; Gaynor AM
    J Clin Virol; 2018 Jul; 104():89-91. PubMed ID: 29803089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of the Alere Determine™ HIV-1/2 Ag/Ab Combo Rapid Test with specimens from HIV-1 seroconverters from the US and HIV-2 infected individuals from Ivory Coast.
    Masciotra S; Luo W; Youngpairoj AS; Kennedy MS; Wells S; Ambrose K; Sprinkle P; Owen SM
    J Clin Virol; 2013 Dec; 58 Suppl 1(Suppl 1):e54-8. PubMed ID: 23911678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance evaluation of the FDA-approved Determine™ HIV-1/2 Ag/Ab Combo assay using plasma and whole blood specimens.
    Masciotra S; Luo W; Westheimer E; Cohen SE; Gay CL; Hall L; Pan Y; Peters PJ; Owen SM
    J Clin Virol; 2017 Jun; 91():95-100. PubMed ID: 28372891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of the new HIV-1/2 diagnostic algorithm in Florida's public health testing population: a review of the first five months of utilization.
    Bennett B; Neumann D; Fordan S; Villaraza R; Crowe S; Gillis L
    J Clin Virol; 2013 Dec; 58 Suppl 1():e29-33. PubMed ID: 24342476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fourth generation Alere
    Livant E; Heaps A; Kelly C; Maharaj R; Samsunder N; Nhlangulela L; Karugaba P; Panchia R; Marrazzo J; Chirenje ZM; Parikh UM;
    J Clin Virol; 2017 Sep; 94():15-21. PubMed ID: 28710996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of early HIV infections using the fourth generation Abbott ARCHITECT HIV Ag/Ab Combo chemiluminescent microparticle immunoassay (CIA) in San Diego County.
    Manlutac AL; Giesick JS; McVay PA
    J Clin Virol; 2013 Dec; 58 Suppl 1():e44-7. PubMed ID: 24342477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of dried blood spot protocols with the Bio-Rad GS HIV Combo Ag/Ab EIA and Geenius™ HIV 1/2 Supplemental Assay.
    Luo W; Davis G; Li L; Shriver MK; Mei J; Styer LM; Parker MM; Smith A; Paz-Bailey G; Ethridge S; Wesolowski L; Owen SM; Masciotra S
    J Clin Virol; 2017 Jun; 91():84-89. PubMed ID: 28366544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poor performance of the determine HIV-1/2 Ag/Ab combo fourth-generation rapid test for detection of acute infections in a National Household Survey in Swaziland.
    Duong YT; Mavengere Y; Patel H; Moore C; Manjengwa J; Sibandze D; Rasberry C; Mlambo C; Li Z; Emel L; Bock N; Moore J; Nkambule R; Justman J; Reed J; Bicego G; Ellenberger DL; Nkengasong JN; Parekh BS
    J Clin Microbiol; 2014 Oct; 52(10):3743-8. PubMed ID: 25122853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of Alere Determine HIV-1/2 Ag/Ab Combo rapid test for acute HIV infection: a case report.
    Lanzafame M; Zorzi A; Rigo F; Adami I; Del Bravo P; Tonolli E; Concia E; Azzini AM
    Infez Med; 2015 Mar; 23(1):48-50. PubMed ID: 25819051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of an alternative HIV diagnostic algorithm using the ARCHITECT HIV Ag/Ab Combo assay and potential utility of sample-to-cutoff ratio to discriminate primary from established infection.
    Ramos EM; Harb S; Dragavon J; Swenson P; Stekler JD; Coombs RW
    J Clin Virol; 2013 Dec; 58 Suppl 1(0 1):e38-43. PubMed ID: 24029686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance comparison of the 4th generation Bio-Rad Laboratories GS HIV Combo Ag/Ab EIA on the EVOLIS™ automated system versus Abbott ARCHITECT HIV Ag/Ab Combo, Ortho Anti-HIV 1+2 EIA on Vitros ECi and Siemens HIV-1/O/2 enhanced on Advia Centaur.
    Mitchell EO; Stewart G; Bajzik O; Ferret M; Bentsen C; Shriver MK
    J Clin Virol; 2013 Dec; 58 Suppl 1():e79-84. PubMed ID: 24342482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Determine™ fourth generation HIV rapid assay.
    Brauer M; De Villiers JC; Mayaphi SH
    J Virol Methods; 2013 Apr; 189(1):180-3. PubMed ID: 23391823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterophilic interference in specimens yielding false-reactive results on the Abbott 4th generation ARCHITECT HIV Ag/Ab Combo assay.
    Lavoie S; Caswell D; Gill MJ; Kadkhoda K; Charlton CL; Levett PN; Hatchette T; Garceau R; Maregmen J; Mazzulli T; Needle R; Kadivar K; Kim J
    J Clin Virol; 2018 Jul; 104():23-28. PubMed ID: 29704735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative multi-assay evaluation of Determine™ HIV-1/2 Ag/Ab Combo rapid diagnostic tests in acute and chronic HIV infection.
    Wratil PR; Rabenau HF; Eberle J; Stern M; Münchhoff M; Friedrichs I; Stürmer M; Berger A; Kuttner-May S; Münstermann D; Lucht A; Meixenberger K; Bannert N; Keppler OT
    Med Microbiol Immunol; 2020 Apr; 209(2):139-150. PubMed ID: 32036450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the performance of the Abbott ARCHITECT HIV Ag/Ab Combo Assay.
    Chavez P; Wesolowski L; Patel P; Delaney K; Owen SM
    J Clin Virol; 2011 Dec; 52 Suppl 1():S51-5. PubMed ID: 21983253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a rapid and simple fourth-generation HIV screening assay for qualitative detection of HIV p24 antigen and/or antibodies to HIV-1 and HIV-2.
    Beelaert G; Fransen K
    J Virol Methods; 2010 Sep; 168(1-2):218-22. PubMed ID: 20561542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BioRad BioPlex® HIV Ag-Ab assay: Incidence of false positivity in a low-prevalence population and its effects on the current HIV testing algorithm.
    Parker J; Carrasco AF; Chen J
    J Clin Virol; 2019 Jul; 116():1-3. PubMed ID: 30981082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of two 4th generation point-of-care assays for the detection of Human Immunodeficiency Virus infection.
    Stafylis C; Klausner JD
    PLoS One; 2017; 12(8):e0183944. PubMed ID: 28846743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Detection Limits of Fourth- and Fifth-Generation Combination HIV Antigen-Antibody, p24 Antigen, and Viral Load Assays on Diverse HIV Isolates.
    Stone M; Bainbridge J; Sanchez AM; Keating SM; Pappas A; Rountree W; Todd C; Bakkour S; Manak M; Peel SA; Coombs RW; Ramos EM; Shriver MK; Contestable P; Nair SV; Wilson DH; Stengelin M; Murphy G; Hewlett I; Denny TN; Busch MP
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29793968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance evaluation of the Bio-Rad Laboratories GS HIV Combo Ag/Ab EIA, a 4th generation HIV assay for the simultaneous detection of HIV p24 antigen and antibodies to HIV-1 (groups M and O) and HIV-2 in human serum or plasma.
    Bentsen C; McLaughlin L; Mitchell E; Ferrera C; Liska S; Myers R; Peel S; Swenson P; Gadelle S; Shriver MK
    J Clin Virol; 2011 Dec; 52 Suppl 1():S57-61. PubMed ID: 21995929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.